Knott David M Jr »

Q32 Bio shares owned by Knott David M Jr

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2026-06-30 $387k 30k 12.74

More positions owned by Knott David M Jr

Alphabet Inc-Cl C Common (GOOG)
Apollo Global Management Common (APO)
Syndax Pharmaceutical Common (SNDX)
Xeris Biopharma Holdings Common (XERS)
Travere Therapeutics Common (TVTX)
Protagonist Therapeutics Common (PTGX)
Bridgebio Pharma Common (BBIO)
Iovance Biotherapeutics Common (IOVA)
Alkermes Common (ALKS)
JPMorgan Chase & Co. Common (JPM)
Janus Henderson AAA CLO ETF Common (JAAA)
LPL Financial Holdings Common
Cogent Biosciences Common (COGT)
TG Therapeutics Common (TGTX)
Catalyst Pharmaceuticals Common (CLST)

View all positions for Knott David M Jr

Top funds holding Q32 Bio

OrbiMed Advisors
Boxer Capital Management
Atlas Venture Life Science Advisors
BVF
RA Capital Management
Point72 Asset Management
Opaleye Management
Logos Global Management
SummitTX Capital
Ikarian Capital
Vanguard Capital Management
Woodline Partners
American Century Companies
Sanofi
Acadian Asset Management

View all funds holding Q32 Bio